Fund HoldingsFCPM III SERVICES B.V.

Total Portfolio Value
$762.89M
Total Bought
$160.77M
Total Sold
$100.47M
Net Transaction
+$60.30M
Filing Period:
Securities
SharesValue ($K)
Q3 2025
Q4 2025
Change
Q3 2025
Q4 2025
Weight (%)
Change
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
9,212,3849,198,900-13,484262,000322,69742.30%+60,697
MAPLIGHT THERAPEUTICS INC(MPLT)03,226,400+3,226,400056,6727.43%+56,672
RAPT THERAPEUTICS INC344,2371,833,333+1,489,0968,87862,0958.14%+53,217
DYNE THERAPEUTICS INC(DYN)5,462,8465,462,846069,105106,85314.01%+37,748
VOR BIOPHARMA INC(VOR)379,6403,617,354+3,237,71418,49647,3156.20%+28,819
ENGENE HOLDINGS INC
COM
9,632,5619,632,561065,79086,98211.40%+21,192
CRESCENT BIOPHARMA INC.01,677,852+1,677,852019,8992.61%+19,899
REPLIMUNE GROUP INC(REPL)4,158,3682,808,368-1,350,00017,42427,2973.58%+9,874
ENGENE HOLDINGS INC
*W EXP 10/31/202
2,878,1482,878,14802,0728,5191.12%+6,447
BICYCLE THERAPEUTICS PLC3,452,3303,468,430+16,10026,72124,5563.22%-2,165
ASTRIA THERAPEUTICS INC4,107,5370-4,107,53729,9030-29,903
Page 1 of 1